妊娠期补充ω-3脂肪酸以降低早产和早期早产风险
本临床实践指南由多个医学科学组织支持制定,基于随机临床试验的强证据和正式共识流程,建议育龄女性每日摄入至少250 mg二十二碳六烯酸+二十碳五烯酸,妊娠期额外补充≥100至200 mg/d二十二碳六烯酸;低摄入或低血水平的孕妇应补充约600至1000 mg/d, preferably从妊娠中期开始至约37周。
要点
- 育龄女性每日应从饮食或补充剂获取至少250 mg二十二碳六烯酸+二十碳五烯酸。
- 妊娠期额外补充≥100至200 mg/d二十二碳六烯酸。
- 低摄入或低血水平的孕妇应补充约600至1000 mg/d二十二碳六烯酸+二十碳五烯酸或单用二十二碳六烯酸。
核心结论
- 孕妇低二十二碳六烯酸摄入和/或低血水平增加早产和早期早产风险,补充约600至1000 mg/d可显著降低早产和早期早产。
研究设计与样本
- 本临床实践指南由多个医学科学组织支持制定,基于随机临床试验的强证据综述和正式共识流程。
主要发现
- 随机对照试验显示约600至1000 mg/d的二十二碳六烯酸+二十碳五烯酸或单用二十二碳六烯酸显著降低早产和早期早产。
- 孕妇低二十二碳六烯酸摄入和/或低血水平与早产和早期早产风险增加相关。
关键数值与推荐
- 育龄女性应从饮食或补充剂获取至少250 mg/d二十二碳六烯酸+二十碳五烯酸。
- 妊娠期额外摄入≥100至200 mg/d二十二碳六烯酸。
- 低摄入或低血水平的孕妇应补充约600至1000 mg/d二十二碳六烯酸+二十碳五烯酸或单用二十二碳六烯酸。
- 额外补充最好从妊娠中期开始(不晚于约20周妊娠),持续至约37周妊娠或分娩(若早于37周)。
- 可通过一组标准化摄入问题识别ω-3供应不足的孕妇;血二十二碳六烯酸测量是另一选择,但需进一步标准化实验室方法和适当 cutoff 值。
临床怎么用
- 应向育龄女性和孕妇及其伴侣提供关于如何达到适当二十二碳六烯酸或二十二碳六烯酸+二十碳五烯酸摄入的信息。
- 识别ω-3供应不足的孕妇可通过标准化摄入问题或血二十二碳六烯酸测量。
局限性
- 血二十二碳六烯酸测量需进一步标准化实验室方法和适当 cutoff 值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This clinical practice guideline on the supply of the omega-3 docosahexaenoic acid and eicosapentaenoic acid in pregnant women for risk reduction of preterm birth and early preterm birth was developed with support from several medical-scientific organizations, and is based on a review of the available strong evidence from randomized clinical trials and a formal consensus process. We concluded the following. Women of childbearing age should obtain a supply of at least 250 mg/d of docosahexaenoic+eicosapentaenoic acid from diet or supplements, and in pregnancy an additional intake of ≥100 to 200 mg/d of docosahexaenoic acid. Pregnant women with a low docosahexaenoic acid intake and/or low docosahexaenoic acid blood levels have an increased risk of preterm birth and early preterm birth. Thus, they should receive a supply of approximately 600 to 1000 mg/d of docosahexaenoic+eicosapentaenoic acid, or docosahexaenoic acid alone, given that this dosage showed significant reduction of preterm birth and early preterm birth in randomized controlled trials. This additional supply should preferably begin in the second trimester of pregnancy (not later than approximately 20 weeks' gestation) and continue until approximately 37 weeks' gestation or until childbirth if before 37 weeks' gestation. Identification of women with inadequate omega-3 supply is achievable by a set of standardized questions on intake. Docosahexaenoic acid measurement from blood is another option to identify women with low status, but further standardization of laboratory methods and appropriate cutoff values is needed. Information on how to achieve an appropriate intake of docosahexaenoic acid or docosahexaenoic+eicosapentaenoic acid for women of childbearing age and pregnant women should be provided to women and their partners.
引用
- Cetin I, Carlson SE, Burden C, et al. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth. Am J Obstet Gynecol MFM. 2023. PMID: 38070679. doi:10.1016/j.ajogmf.2023.101251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。